Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain.
Reproductive Medicine Research Group, Instituto de Investigación Sanitaria La Fe, La Fe University Hospital, Valencia, Spain.
Fertil Steril. 2015 Oct;104(4):1037-1046.e1. doi: 10.1016/j.fertnstert.2015.07.001. Epub 2015 Jul 23.
To determine whether there is any difference in the follicular fluid (FF) microRNA (miRNA) profiles from in vitro fertilization (IVF) patients according to their age and oocyte maturation stage.
Observational prospective study.
IVF clinic/hospital facilities.
PATIENTS(S): We included 30 women with primary infertility undergoing intracytoplasmic sperm injection treatment and excluded patients with polycystic ovarian syndrome, endometriosis, severe male factor, and low ovarian reserve.
INTERVENTION(S): After the collection of FF and granulosa cells from each patient, the samples were processed for total RNA extraction. RNA was pooled into different groups (three samples per pool) for microarray analysis to evaluate the expression of a total of 866 human miRNAs. Individual samples were analyzed to validate the pooled microarray results using real-time polymerase chain reaction.
MAIN OUTCOME MEASURE(S): Evaluation of the expression of a total of 866 human miRNAs in FF and granulosa cells.
RESULT(S): We identified only one differentially expressed miRNA, hsa-miR-424, which is present in higher proportions in FF from patients with advanced age. When we compared the FF from metaphase II (MII) versus GV (germinal vesicle) oocytes, we found 13 differentially expressed miRNAs (two up- and 11 downregulated). When we compared FF from MII versus MI, we found seven differentially expressed miRNAs in MII (three up- and four downregulated).
CONCLUSION(S): We have described the FF miRNA profiles according to IVF patients' age and the maturation stage of their oocytes. This descriptive study may aid our understanding of the physiology and regulation of oocyte maturation and could identify some potential miRNA biomarkers for this process.
Not applicable.
根据体外受精(IVF)患者的年龄和卵母细胞成熟阶段,确定卵泡液(FF)microRNA(miRNA)谱是否存在差异。
观察性前瞻性研究。
IVF 诊所/医院设施。
我们纳入了 30 名患有原发性不孕的女性,接受胞浆内精子注射治疗,并排除了多囊卵巢综合征、子宫内膜异位症、严重男性因素和低卵巢储备的患者。
从每位患者采集 FF 和颗粒细胞后,处理样本进行总 RNA 提取。将 RNA 分成不同的组(每组三个样本)进行微阵列分析,以评估总共 866 个人类 miRNA 的表达。使用实时聚合酶链反应分析单个样本,以验证微阵列结果的汇集。
评估 FF 和颗粒细胞中总共 866 个人类 miRNA 的表达。
我们仅鉴定出一种差异表达的 miRNA,hsa-miR-424,其在高龄患者的 FF 中比例更高。当我们比较中期 II(MII)与卵母细胞原始核(GV)的 FF 时,我们发现 13 种差异表达的 miRNA(两种上调和 11 种下调)。当我们比较 MII 与 MI 的 FF 时,我们发现 MII 中有 7 种差异表达的 miRNA(三种上调和四种下调)。
我们根据 IVF 患者的年龄和卵母细胞的成熟阶段描述了 FF miRNA 谱。这项描述性研究可能有助于我们了解卵母细胞成熟的生理学和调控,并可能为这一过程确定一些潜在的 miRNA 生物标志物。
不适用。